Cyclacel Pharmaceuticals announces 1-for-15 reverse stock split

6 days ago 1

Cyclacel Pharmaceuticals (NASDAQ:CYCC) announced on Wednesday that it expects to implement a 1-for-15 reverse stock split on its shares of common stock effective July 7, 2025, with trading to begin on a split-adjusted basis at the market open on that day.

Recommended For You